These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30324897)

  • 21. Current practice of ototoxicity management across the United Kingdom (UK).
    Maru D; Malky GA
    Int J Audiol; 2018 Sep; 57(sup4):S76-S88. PubMed ID: 29676584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy.
    Brown ECM; Caimino C; Benton CL; Baguley DM
    J Laryngol Otol; 2021 Jan; 135(1):14-20. PubMed ID: 33487183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring neonates for ototoxicity.
    Garinis AC; Kemph A; Tharpe AM; Weitkamp JH; McEvoy C; Steyger PS
    Int J Audiol; 2018 Sep; 57(sup4):S41-S48. PubMed ID: 28949262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using tablet-based technology to deliver time-efficient ototoxicity monitoring.
    Brungart D; Schurman J; Konrad-Martin D; Watts K; Buckey J; Clavier O; Jacobs PG; Gordon S; Dille MF
    Int J Audiol; 2018 Sep; 57(sup4):S25-S33. PubMed ID: 28893111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical factors associated with utilisation of ototoxicity monitoring services for multi-drug-resistant tuberculosis patients in the Western Cape.
    Ramma L; Nhokwara PT; Rogers C
    S Afr J Commun Disord; 2019 Jan; 66(1):e1-e6. PubMed ID: 30843411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ototoxicity management: An investigation into doctors' knowledge and practices, and the roles of audiologists in a tertiary hospital.
    Wium A; Gerber B
    S Afr J Commun Disord; 2016 Dec; 63(1):e1-e15. PubMed ID: 28155308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audiologic monitoring for ototoxicity.
    Campbell KC; Durrant J
    Otolaryngol Clin North Am; 1993 Oct; 26(5):903-14. PubMed ID: 8233496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ototoxicity: A Challenge in Diagnosis and Treatment.
    Ganesan P; Schmiedge J; Manchaiah V; Swapna S; Dhandayutham S; Kothandaraman PP
    J Audiol Otol; 2018 Apr; 22(2):59-68. PubMed ID: 29471610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.
    Knight KR; Chen L; Freyer D; Aplenc R; Bancroft M; Bliss B; Dang H; Gillmeister B; Hendershot E; Kraemer DF; Lindenfeld L; Meza J; Neuwelt EA; Pollock BH; Sung L
    J Clin Oncol; 2017 Feb; 35(4):440-445. PubMed ID: 27937095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of highly active antiretroviral therapy in South Africa.
    Badri M; Maartens G; Mandalia S; Bekker LG; Penrod JR; Platt RW; Wood R; Beck EJ
    PLoS Med; 2006 Jan; 3(1):e4. PubMed ID: 16318413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist-administered audiology screening for pediatric cystic fibrosis patients exposed to high-dose aminoglycosides: A pilot study.
    McKinzie CJ; Kam CW; Parry R; Darby M; Tak CR
    Pediatr Pulmonol; 2022 Jul; 57(7):1814-1817. PubMed ID: 35485261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-Based Ototoxicity Monitoring for Drug-Resistant Tuberculosis in South Africa: An Evaluation Study.
    Stevenson LJ; Biagio-de Jager L; Graham MA; Swanepoel W
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa.
    Dong K; Thabethe Z; Hurtado R; Sibaya T; Dlwati H; Walker B; Wilson D
    J Infect Dis; 2007 Dec; 196 Suppl 3():S491-6. PubMed ID: 18181699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Availability of audiological equipment and protocols for paediatric assessment and hearing aid fitting in Gauteng, South Africa.
    Teixeira L; Joubert K
    S Afr J Commun Disord; 2014 Aug; 61(1):. PubMed ID: 26305438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing and Verifying Hearing Aids Applying the American Academy of Audiology Pediatric Amplification Guideline: Protocols and Outcomes from the Ontario Infant Hearing Program.
    Bagatto M; Moodie S; Brown C; Malandrino A; Richert F; Clench D; Scollie S
    J Am Acad Audiol; 2016 Mar; 27(3):188-203. PubMed ID: 26967361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public awareness of audiology, hearing and hearing health in the Limpopo Province, South Africa.
    Joubert K; Sebothoma B; Kgare KS
    S Afr J Commun Disord; 2017 Sep; 64(1):e1-e9. PubMed ID: 29041791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
    Hong H; Dooley KE; Starbird LE; Francis HW; Farley JE
    Arch Toxicol; 2019 May; 93(5):1385-1399. PubMed ID: 30963202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ototoxicity monitoring in children treated with platinum chemotherapy.
    Brooks B; Knight K
    Int J Audiol; 2018 Sep; 57(sup4):S34-S40. PubMed ID: 28737048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.